Latest Breaking News On - Brookline capital management - Page 9 : comparemela.com

Lantheus Holdings, Inc (NASDAQ:LNTH) Receives Average Recommendation of Moderate Buy from Analysts

Lantheus Holdings, Inc. (NASDAQ:LNTH – Get Free Report) has earned an average rating of “Moderate Buy” from the seven brokerages that are covering the company, Marketbeat.com reports. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. The average 12-month price objective among brokerages […]

Paul blanchfieldBanque cantonale vaudoiseMary anne heinoNorthcrest asset manangementLantheus holdings incLantheus company profileEagle health investmentsComerica bankLantheus holdingsGet free reportBrookline capital managementPresident paul blanchfieldAnne heinoCantonale vaudoiseCrest asset manangementHealth investments

Outlook Therapeutics (NASDAQ:OTLK) Upgraded by Brookline Capital Management to Buy

Brookline Capital Management upgraded shares of Outlook Therapeutics (NASDAQ:OTLK – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday, Benzinga reports. They currently have $1.57 price target on the stock. Other research analysts also recently issued research reports about the stock. Guggenheim upgraded shares of […]

Capital partnersGables capital management incVanguard group incOutlook therapeutics incScotia capital incBrookline capital managementOutlook therapeuticsFree reportCapital marketsCapital one financialModerate buyGet free reportCapital managementOutlook therapeutics dailyNasdaq otlk

Equities Research Analysts Upgrades for January 25th (AKAM, ALTI, AMIGY, CAR, CORZ, CVLG, EFX, FCCO, FNB, GPK)

Equities Research Analysts Upgrades for January 25th (AKAM, ALTI, AMIGY, CAR, CORZ, CVLG, EFX, FCCO, FNB, GPK)
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

United statesRaymond jamesOppenheimer holdings incTriumph groupNeedham companyMarvell technologyFirst communityDz bankNews ratings for akamai technologies inc dailyInovio pharmaceuticalsAmerica coCitigroup incEquities research analystTruist financial coAdmiral groupNational bankshares inc

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Receives Consensus Recommendation of Hold from Analysts

Oncternal Therapeutics, Inc (NASDAQ:ONCT) Receives Consensus Recommendation of Hold from Analysts
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Mirabella financial servicesHealthcare of ontario pension plan trust fundVanguard group incRenaissance technologiesOncternal therapeutics incOncternal therapeuticsGet free reportBrookline capital managementOntario pension plan trust fundFinancial servicesTherapeutics stock downGet freeOrphan receptorOncternal therapeutics daily

Short Interest in Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Drops By 13 3%

Short Interest in Cyclacel Pharmaceuticals, Inc (NASDAQ:CYCC) Drops By 13 3%
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Roth mkmCyclacel pharmaceuticals incCyclacel pharmaceuticals stock performanceRenaissance technologiesVirtu financialMillennium managementCyclacel pharmaceuticalsHedge funds weigh in on cyclacel pharmaceuticalsNews ratings for cyclacel pharmaceuticals dailyGet free reportSigma investmentsBrookline capital managementCyclacel pharmaceuticals daily